Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study

BACKGROUND: Liraglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog, has several non- glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown. METHODS: A prospective study of 8 months duration in 64 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Manfredi, Chandalia, Manisha, Patti, Angelo Maria, Di Bartolo, Vittoria, Rizvi, Ali A, Montalto, Giuseppe, Abate, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948058/
https://www.ncbi.nlm.nih.gov/pubmed/24559258
http://dx.doi.org/10.1186/1475-2840-13-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948058/
https://www.ncbi.nlm.nih.gov/pubmed/24559258
http://dx.doi.org/10.1186/1475-2840-13-49

Ejemplares similares